IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY20 results · Apr–Jun 2019
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹492.80 crore (up 36.2% from Q1 FY19) and net profit of ₹85.32 crore (up 492.1% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a standalone basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 492.80 | 361.84 | +36.2% | 422.29 | +16.7% |
| Other income | 3.32 | 3.56 | −6.7% | 2.20 | +50.9% |
| Total income | 496.12 | 365.40 | +35.8% | 424.49 | +16.9% |
| Profit before tax | 131.02 | 19.67 | +566.1% | 142.52 | −8.1% |
| Net profit for the period | 85.32 | 14.41 | +492.1% | 101.65 | −16.1% |
| EPS, basic (₹) | 15.00 | 2.56 | +485.9% | 18.08 | −17.0% |
| Net margin (%) | 17.3 | 4.0 | 24.1 |
Standalone
- Filed with BSE
- 13 Aug 2019, 16:12 IST
- Board meeting
- 12 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE